-
-
-
-
-
-
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Repligen (RGEN)
-
-
-
-
-
-
-
Repligen (RGEN) Launches Novel AVIPure dsRNA Resin in OPUSĀ® Pre-packed Columns
-
-
-
-
-
-
-
Repligen (RGEN) to Acquire Chromatography Innovator Tantti
-
-
-
-
-
-
-
Repligen (RGEN) to Acquire Fluid Management Innovator Metenova
-
-
-
-
-
-
-
Repligen Appoints Martin D. Madaus to Board of Directors
-
-
-
-
-
-
-
Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
-
1,158,406 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

